• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[成人使用精神刺激药物呈上升趋势]

[Upward trend in the use of psychostimulants by adults].

作者信息

van der Koog L, van der Schans J, Tjioe M A, Bos J H J, Bijker B J, Hak E, Schuiling-Veninga C C M

机构信息

Rijkuniversiteit Groningen, Groningen Research Institute of Pharmacy, afd. Farmacotherapie, -Epidemiologie & -Economie, Groningen.

出版信息

Ned Tijdschr Geneeskd. 2017;161:D1660.

PMID:29098969
Abstract

OBJECTIVE

To gain insight into the trends in the use of psychostimulants among adults.

DESIGN

Retrospective database study.

METHODS

We selected data on adults (≥ 18 years) who had had a minimum of 2 prescriptions for a psychostimulant drug within 1 year from IADB.nl, a Netherlands database of filled prescriptions (59 public pharmacies, approximately 600,000 patients). We calculated both the number of new users and the total number of users of psychostimulants per year in the period 2004-2014. We also assessed which agent was the most commonly prescribed psychostimulant drug and who had initiated treatment.

RESULTS

The number of adults who were prescribed psychostimulants (methylphenidate, dexamphetamine and amphetamine) increased from 1.5 per 1000 adults in 2004 to 7.8 per 1000 adults in 2014. Users were mainly male (63.0%) and methylphenidate was the most frequently prescribed agent (85.7%). The number of new users of these agents increased from 0.5 to 1.5 per 1000 adults, and the greatest increase was observed among young adults (< 30 years). The increase in new users seems to have stabilized since 2012. Around 40% of new treatments were initiated by the GP.

CONCLUSION

The large increase in the number of adults who are prescribed psychostimulants seems mainly to be the result of an increase in the number of new users, especially among young adults. As psychostimulants are only approved for the treatment of ADHD in children from 6 years of age and in adolescents, short- and long-term effects and side effects of these drugs need to be better assessed in the adult population.

摘要

目的

深入了解成人使用精神振奋剂的趋势。

设计

回顾性数据库研究。

方法

我们从IADB.nl(荷兰一个已配药处方数据库,涵盖59家公立药房,约60万名患者)选取了在1年内至少有2次精神振奋剂药物处方的成人(≥18岁)数据。我们计算了2004 - 2014年期间每年精神振奋剂的新使用者数量和使用者总数。我们还评估了哪种药物是最常处方的精神振奋剂以及谁开始了治疗。

结果

开具精神振奋剂(哌醋甲酯、右旋苯丙胺和苯丙胺)的成人数量从2004年的每1000名成人1.5例增加到2014年的每1000名成人7.8例。使用者主要为男性(63.0%),哌醋甲酯是最常处方的药物(85.7%)。这些药物的新使用者数量从每1000名成人0.5例增加到1.5例,在年轻人(<30岁)中增幅最大。自2012年以来,新使用者的增加似乎已趋于稳定。约40%的新治疗由全科医生发起。

结论

开具精神振奋剂的成人数量大幅增加似乎主要是新使用者数量增加的结果,尤其是在年轻人中。由于精神振奋剂仅被批准用于治疗6岁及以上儿童和青少年的注意力缺陷多动障碍,因此需要在成人人群中更好地评估这些药物的短期和长期影响及副作用。

相似文献

1
[Upward trend in the use of psychostimulants by adults].[成人使用精神刺激药物呈上升趋势]
Ned Tijdschr Geneeskd. 2017;161:D1660.
2
Psychostimulant prescriptions by psychiatrists higher than expected: a self-report survey.精神科医生开具的精神兴奋剂处方高于预期:一项自我报告调查。
Can J Psychiatry. 1999 Sep;44(7):680-4. doi: 10.1177/070674379904400705.
3
Prescription of methylphenidate to children and youth, 1990-1996.1990 - 1996年向儿童和青少年开具哌甲酯处方的情况
CMAJ. 2001 Nov 27;165(11):1489-94.
4
Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.儿童和青少年注意缺陷多动障碍患者兴奋剂的重叠处方。
Psychiatr Serv. 2012 Oct;63(10):1011-8. doi: 10.1176/appi.ps.201100473.
5
Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study.爱尔兰儿科人群中精神兴奋剂的处方趋势:一项全国队列研究。
BMC Pediatr. 2015 Sep 10;15:118. doi: 10.1186/s12887-015-0435-3.
6
Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.哌甲酯:7年期间成人及儿童群体中的性别趋势。
Therapie. 2017 Dec;72(6):635-641. doi: 10.1016/j.therap.2017.05.005. Epub 2017 Jul 21.
7
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.注意缺陷多动障碍儿童及青少年从哌甲酯或苯丙胺转换为托莫西汀的初步耐受性和疗效研究
Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017.
8
Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006.2001年至2006年期间荷兰开始使用速释或缓释哌甲酯或托莫西汀的儿童、青少年及成人的发病率和特征趋势
J Child Adolesc Psychopharmacol. 2010 Feb;20(1):55-61. doi: 10.1089/cap.2008.0153.
9
A Prescription Trend Analysis of Methylphenidate: Relation to Study Reports on Efficacy.哌醋甲酯处方趋势分析:与疗效研究报告的关系。
Adm Policy Ment Health. 2020 Mar;47(2):291-299. doi: 10.1007/s10488-019-00983-6.
10
Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.2001年至2012年斯洛文尼亚儿童和青少年注意力缺陷/多动障碍药物消费趋势:一项从国家层面进行的药物使用研究。
J Child Adolesc Psychopharmacol. 2015 Apr;25(3):254-9. doi: 10.1089/cap.2014.0071. Epub 2015 Mar 24.

引用本文的文献

1
ADHD medication dispensing trends in Dutch youth before and after the implementation of the Youth Act (2010-2022).《青少年法案》实施前后荷兰青少年多动症药物的配药趋势(2010 - 2022年)
Eur Child Adolesc Psychiatry. 2025 Jun 23. doi: 10.1007/s00787-025-02791-w.